Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ependymoma | 2 | 2021 | 247 | 1.110 |
Why?
|
| Retinal Neoplasms | 2 | 2021 | 144 | 0.830 |
Why?
|
| Retinoblastoma | 2 | 2021 | 200 | 0.830 |
Why?
|
| Brain Neoplasms | 6 | 2023 | 4838 | 0.580 |
Why?
|
| Pyrazoles | 1 | 2021 | 1479 | 0.430 |
Why?
|
| Pyrimidines | 2 | 2021 | 3538 | 0.390 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 609 | 0.370 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 2233 | 0.360 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 3892 | 0.300 |
Why?
|
| Sertoli-Leydig Cell Tumor | 1 | 2022 | 19 | 0.210 |
Why?
|
| Child | 12 | 2023 | 29132 | 0.210 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2017 | 505 | 0.200 |
Why?
|
| Receptor, trkB | 1 | 2021 | 53 | 0.200 |
Why?
|
| Neoplastic Syndromes, Hereditary | 2 | 2022 | 221 | 0.190 |
Why?
|
| Ribonuclease III | 1 | 2022 | 182 | 0.190 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 235 | 0.180 |
Why?
|
| Gadolinium | 1 | 2021 | 165 | 0.180 |
Why?
|
| Ganglioglioma | 1 | 2020 | 41 | 0.180 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2022 | 255 | 0.180 |
Why?
|
| Supratentorial Neoplasms | 1 | 2020 | 80 | 0.180 |
Why?
|
| DNA Polymerase II | 1 | 2019 | 59 | 0.180 |
Why?
|
| Early Diagnosis | 1 | 2021 | 302 | 0.170 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 109 | 0.170 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2019 | 177 | 0.170 |
Why?
|
| Genetic Counseling | 1 | 2021 | 380 | 0.160 |
Why?
|
| Glioma | 2 | 2021 | 1940 | 0.160 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2022 | 469 | 0.160 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2017 | 36 | 0.150 |
Why?
|
| Azepines | 1 | 2018 | 129 | 0.150 |
Why?
|
| Neuroimaging | 1 | 2020 | 404 | 0.140 |
Why?
|
| Panniculitis | 1 | 2017 | 58 | 0.140 |
Why?
|
| Aurora Kinase A | 1 | 2018 | 207 | 0.140 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 1071 | 0.140 |
Why?
|
| Oximes | 1 | 2017 | 176 | 0.140 |
Why?
|
| Germinoma | 1 | 2016 | 84 | 0.130 |
Why?
|
| Cyclin B | 1 | 2014 | 63 | 0.120 |
Why?
|
| Radiation Dosage | 1 | 2019 | 1016 | 0.120 |
Why?
|
| Oncogene Fusion | 1 | 2014 | 63 | 0.120 |
Why?
|
| Medulloblastoma | 1 | 2019 | 541 | 0.120 |
Why?
|
| Benzimidazoles | 1 | 2017 | 428 | 0.120 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 2281 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 481 | 0.120 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 1517 | 0.110 |
Why?
|
| Child, Preschool | 6 | 2020 | 16260 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2015 | 972 | 0.110 |
Why?
|
| Mass Screening | 1 | 2021 | 1505 | 0.110 |
Why?
|
| Mutation, Missense | 1 | 2017 | 1154 | 0.100 |
Why?
|
| Imidazoles | 1 | 2017 | 1004 | 0.100 |
Why?
|
| Indoles | 1 | 2017 | 1011 | 0.100 |
Why?
|
| Infant | 5 | 2019 | 13309 | 0.100 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 1284 | 0.090 |
Why?
|
| Humans | 16 | 2023 | 262282 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 5156 | 0.080 |
Why?
|
| DNA Mismatch Repair | 2 | 2022 | 268 | 0.080 |
Why?
|
| Chemoradiotherapy | 1 | 2017 | 1947 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2017 | 1826 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8231 | 0.080 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 3583 | 0.080 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2014 | 883 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2018 | 1799 | 0.070 |
Why?
|
| Mutation | 4 | 2023 | 15182 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2014 | 1663 | 0.070 |
Why?
|
| Biomarkers, Tumor | 4 | 2023 | 10348 | 0.070 |
Why?
|
| Antineoplastic Agents | 3 | 2018 | 14302 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 4660 | 0.070 |
Why?
|
| Germ-Line Mutation | 2 | 2022 | 1047 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 2485 | 0.070 |
Why?
|
| Genomics | 1 | 2016 | 2746 | 0.060 |
Why?
|
| Sarcoma | 1 | 2014 | 1725 | 0.060 |
Why?
|
| Male | 8 | 2021 | 123330 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 10025 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 10070 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 4770 | 0.050 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2022 | 178 | 0.050 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2022 | 206 | 0.050 |
Why?
|
| Prognosis | 2 | 2016 | 21744 | 0.050 |
Why?
|
| Ophthalmic Artery | 1 | 2019 | 26 | 0.040 |
Why?
|
| Radiation Exposure | 1 | 2019 | 73 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2019 | 233 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2022 | 4790 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2023 | 2304 | 0.040 |
Why?
|
| Germ Cells | 1 | 2019 | 338 | 0.040 |
Why?
|
| Adolescent | 4 | 2020 | 31272 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 238 | 0.040 |
Why?
|
| Phenotype | 2 | 2019 | 6262 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 7554 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 642 | 0.030 |
Why?
|
| Female | 7 | 2022 | 142298 | 0.030 |
Why?
|
| Brain | 2 | 2021 | 4109 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 434 | 0.030 |
Why?
|
| Contrast Media | 1 | 2021 | 1475 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 5540 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 2288 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 734 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 1684 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 1750 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 1871 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 3023 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 1587 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3817 | 0.020 |
Why?
|
| Precision Medicine | 1 | 2016 | 1160 | 0.020 |
Why?
|
| Patient Selection | 1 | 2016 | 2061 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 2481 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 1439 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 38027 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 4900 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 5386 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 5057 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2334 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 5123 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 12983 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 7223 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 7731 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 9197 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 7604 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 14559 | 0.010 |
Why?
|
| Animals | 2 | 2018 | 59534 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 21503 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 70369 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 78140 | 0.000 |
Why?
|
| Middle Aged | 1 | 2014 | 86506 | 0.000 |
Why?
|